Why did Zacks Investment Research assign an 'Underperform' recommendation to Valhi Inc?

Zacks assigned an 'Underperform' recommendation to Valhi Inc. due to persistent challenges in its Chemicals business—which accounts for nearly 90% of its revenues—including pricing pressure in the titanium dioxide market, weak demand, and rising costs that are negatively impacting profitability and financial flexibility.

What segments of Valhi Inc. provide stability despite the challenges in its core business?

Despite the headwinds in its Chemicals business, Valhi Inc.'s Component Products and Real Estate segments provide some stability, and its stock trades at a discount to industry averages.

Zacks Initiates Coverage of Valhi Inc with Underperform Recommendation

Jul 2, 2026

Zacks Investment Research initiated coverage of Valhi Inc with an "Underperform" recommendation due to challenges in its chemical segment. The report cites pricing pressure in the titanium dioxide market and rising costs impacting profitability despite some stability in other segments.

TradingView

Zacks Initiates Coverage of VHI With Underperform Recommendation

The Globe and Mail

2026-03-04

Bayer’s net loss deepens on litigation costs; sees flat earnings, sales in 2026

2026-03-13

Valhi (VHI) Quarterly Loss Deepens To US$53.2 Million Challenging Low P/S Bull Case

2026-03-13

Valhi (NYSE: VHI) outlines TiO2 leadership, debt load and Nevada land

2026-03-14

Valhi (NYSE:VHI) Raised to Hold at Wall Street Zen